QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Cannabis Conference
InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, will be participating in the 4th annual Cowen Cannabis Conference. InMed’s management team will be presenting in the three-day event, which is scheduled for Nov. 29–Dec. 1, 2021. During the virtual conference, InMed representatives will meet virtually one-on-one with institutional and corporate clients of the firm. The agenda for the annual cannabis conference features topical panel discussions with C-Suite presenters. The event is hosted by Cowen Research and Washington Research Group analysts. To view the full press releases, visit https://ibn.fm/n3gsi About InMed Pharmaceuticals Inc. InMed Pharmaceuticals is a…